This website uses cookies to give you the best user experience. If you continue
without changing your settings we'll assume you are happy to receive all RSC cookies.
You can change your cookie settings by navigating to our Privacy and Cookies page and following the instructions. These instructions
are also obtainable from the privacy link at the bottom of any RSC page.
Discovery of novel SERMs with a ferrocenyl entity based on the oxabicyclo[2.2.1]heptene scaffold and evaluation of their antiproliferative effects in breast cancer cells
Laboratory of Combinatorial Biosynthesis and Drug Discovery (Wuhan University), Ministry of Education, State Key Laboratory of Virology, Wuhan University School of Pharmaceutical Sciences, Wuhan, China
E-mail: zhouhb@whu.edu.cn
; Fax: +86-27-68759850
; Tel: +86-27-68759586
b
College of Life Sciences, Wuhan University, Wuhan, China
E-mail: jianhuang@whu.edu.cn
; Tel: +86 27 68753582
Org. Biomol. Chem., 2012,10, 9689-9699
DOI:
10.1039/C2OB26226F
Received
27 Jun 2012,
Accepted
23 Oct 2012
First published online
24 Oct 2012
We have synthesized a series of novel SERMs bearing a ferrocenyl unit based on a three-dimensional oxabicyclo[2.2.1]heptene core scaffold. These compounds displayed high receptor binding affinities as well as ERα or ERβ selectivity. In cell proliferation assays, we found that these ligands were cytotoxic at micromolar concentrations in both ER-positive and ER-negative breast cancer cells. On further examination, we found that the antiproliferative effects of compounds 9b, 10h and 11b on MCF-7 cells line does not arise from antiestrogenicity, but rather proceeds through a cytotoxic pathway. Possible mechanisms for the unique activities of these ligands were also investigated by molecular modeling. These new ligands could act as scaffolds for the development of novel anti-breast cancer agents.
Fetching data from CrossRef. This may take some time to load.
Organic & Biomolecular Chemistry
- Information Point